Health

Results: 721-732 of 8097

BetaGlue Therapeutics Receives Belgium Ministry of Health Approval for YntraDose Clinical Trial in Unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)

OKYO Pharma Announces Chairman and Founder Acquires Shares

Silence Therapeutics Announces Leadership Changes

Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution

PR Newswire associated0

Rona Therapeutics Advances INHBE siRNA Into Phase 1 Clinical Development

Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering

SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion

GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe

PR Newswire associated0

Medit Announces 2025 Year-End Promotion

PR Newswire associated0

Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score

Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ DrillPin

Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout